BMI-1 activation is crucial in hTERT-induced epithelial-mesenchymal transition of oral epithelial cells

Experimental and Molecular Pathology

Volumn 95, Issue 1, 2013, Pages 57-61

  Qiao, Bin ^a   Chen, Zhifeng ^b   Hu, Fengchun ^b   Tao, Qian ^b   Lam, Alfred K ^c,d  

^a THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

^c GRIFFITH UNIVERSITY   (Australia)

^d GRIFFITH UNIVERSITY   (Australia)

Author keywords

BMI 1; EMT; HTERT; Immortalisation

Indexed keywords

BMI1 PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 2A; CYTOKERATIN; SMALL INTERFERING RNA; TELOMERASE REVERSE TRANSCRIPTASE; TRANSCRIPTION FACTOR TWIST; UVOMORULIN; VIMENTIN;

ARTICLE; CELL IMMORTALIZATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; EPIDERMIS CELL; EPITHELIAL MESENCHYMAL TRANSITION; EPITHELIUM CELL; GENE SILENCING; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; MOUTH MUCOSA; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRAL GENE DELIVERY SYSTEM; WESTERN BLOTTING;

BMI-1; EMT; HTERT; IMMORTALISATION;

CELL LINE, TRANSFORMED; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DOWN-REGULATION; EPITHELIAL CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; HUMANS; KERATINOCYTES; MOUTH MUCOSA; POLYCOMB REPRESSIVE COMPLEX 1; RNA, SMALL INTERFERING; STEM CELLS; TELOMERASE; VIMENTIN;

EID: 84879129284     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2013.05.004     Document Type: Article

References (41)

1. Boukamp P., Petrussevska R.T., Breitkreutz D., et al. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. The Journal of Cell Biology 1988, 106:761-771.
2. Boukamp P., Popp S., Altmeyer S., et al. Sustained nontumorigenic phenotype correlates with a largely stable chromosome content during long-term culture of the human keratinocyte line HaCaT. Genes, Chromosomes & Cancer 1997, 19:201-214.
3. Chow V., Law S., Lam K.Y., et al. Telomerase activity in small cell esophageal carcinoma. Diseases of the Esophagus 2001, 14:139-142.
4. Egbuniwe O., Idowu B.D., Funes J.M., et al. P16/p53 expression and telomerase activity in immortalized human dental pulp cells. Cell Cycle 2011, 10:3912-3919.
5. Härle-Bachor C., Boukamp P. Telomerase activity in the regenerative basal layer of the epidermis in human skin and in immortal and carcinoma-derived skin keratinocytes. Proceedings of the National Academy of Sciences of the United States of America 1996, 93:6476-6481.
6. Itahana K., Zou Y., Itahana Y., et al. Control of the replicative life span of human fibroblasts by p16 and the polycomb protein Bmi-1. Molecular and Cellular Biology 2003, 23:389-401.
7. Jang da H., Oh J.E., Kang H.K., et al. Spontaneous tumorigenicity of primary human oral keratinocytes with human papillomavirus negativity and impaired apoptosis. International Journal of Oncology 2010, 36:1491-1501.
8. Jiang X.R., Jimenez G., Chang E., et al. Telomerase expression in human somatic cells does not induce changes associated with a transformed phenotype. Nature Genetics 1999, 21:111-114.
9. Kim R.H., Kang M.K., Shin K.H., et al. Bmi-1 cooperates with human papillomavirus type 16 E6 to immortalize normal human oral keratinocytes. Experimental Cell Research 2007, 313:462-472.
10. Lam K.Y., Lo C.Y., Fan S.T., et al. Telomerase activity in pancreatic endocrine tumours: a potential marker for malignancy. Journal of Clinical Pathology-Molecular Pathology 2000, 53:133-136.
11. Lam K.Y., Law S., Tung P.H., et al. Esophageal basaloid squamous cell carcinoma: a unique clinicopathological entity with telomerase activity as a prognostic indicator. The Journal of Pathology 2001, 195:435-442.
12. Lam A.K., Ong K., Giv M.J., et al. p16 expression in colorectal adenocarcinoma: marker of aggressiveness and morphological types. Pathology 2008, 40:580-585.
13. Lam A.K., Ong K., Ho Y.H. Aurora kinase expression in colorectal adenocarcinoma: correlations with clinicopathological features, p16 expression, and telomerase activity. Human Pathology 2008, 39:599-604.
14. Lam A.K., Ong K., Ho Y.H. hTERT expression in colorectal adenocarcinoma: correlations with p21, p53 expressions and clinicopathological features. International Journal of Colorectal Disease 2008, 23:587-594.
15. Lam A.K., Saleh S., Smith R.A., et al. Quantitative analysis of survivin in colorectal adenocarcinoma: increased expression and correlation with telomerase activity. Human Pathology 2008, 39:1229-1233.
16. Lee K., Adhikary G., Balasubramanian S., et al. Expression of Bmi-1 in epidermis enhances cell survival by altering cell cycle regulatory protein expression and inhibiting apoptosis. The Journal of Investigative Dermatology 2008, 128:9-17.
17. Liu Y., El-Naggar S., Darling D.S., et al. Zeb1 links epithelial-mesenchymal transition and cellular senescence. Development 2008, 135:579-588.
18. Liu Z.G., Liu L., Xu L.H., et al. Bmi-1 induces radioresistance in MCF-7 mammary carcinoma cells. Oncology Reports 2012, 27:1116-1122.
19. Liu Z., Li Q., Li K., et al. Telomerase reverse transcriptase promotes epithelial-mesenchymal transition and stem cell-like traits in cancer cells. Oncogene 2012, 10.1038/onc.2012.441.
20. Lo C.Y., Lam K.Y. Telomerase activity in thyroid malignancy. Thyroid 1999, 112:263-270.
21. Lundberg A.S., Hahn W.C., Gupta P., et al. Genes involved in senescence and immortalization. Current Opinion in Cell Biology 2000, 12:705-709.
22. Maurelli R., Zambruno G., Guerra L., et al. Inactivation of p16INK4a (inhibitor of cyclin-dependent kinase 4A) immortalizes primary human keratinocytes by maintaining cells in the stem cell compartment. The FASEB Journal 2006, 20:1516-1518.
23. McMurray H.R., McCance D.J. Degradation of p53, not telomerase activation, by E6 is required for bypass of crisis and immortalization by human papillomavirus type 16 E6/E7. Journal of Virology 2004, 78:5698-5706.
24. Muntoni A., Fleming J., Gordon K.E., et al. Senescing oral dysplasias are not immortalized by ectopic expression of hTERT alone without other molecular changes, such as loss of INK4A and/or retinoic acid receptor-beta: but p53 mutations are not necessarily required. Oncogene 2003, 22:7804-7808.
25. Nakamura M., Tokura Y. Epithelial-mesenchymal transition in the skin. Journal of Dermatological Science 2011, 61:7-13.
26. Park I.K., Morrison S.J., Clarke M.F. Bmi1, stem cells, and senescence regulation. The Journal of Clinical Investigation 2004, 113:175-179.
27. Qiao B., Gopalan V., Chen Z., et al. Epithelial-mesenchymal transition and mesenchymal-epithelial transition are essential for the acquisition of stem cell properties in hTERT-immortalised oral epithelial cells. Biology of the Cell 2012, 104:476-489.
28. Rheinwald J.G., Hahn W.C., Ramsey M.R., et al. A two-stage, p16 (INK4A)- and p53-dependent keratinocyte senescence mechanism that limits replicative potential independent of telomere status. Molecular and Cellular Biology 2002, 22:5157-5172.
29. Rosivatz E., Becker I., Specht K., et al. Differential expression of the epithelial-mesenchymal transition regulators snail, SIP1, and twist in gastric cancer. American Journal of Pathology 2002, 161:1881-1891.
30. Saleh S., Lam A.K., Gertraud Buettner P., et al. Telomerase activity of basal cell carcinoma in patients living in North Queensland, Australia. Human Pathology 2007, 38:1023-1029.
31. Saleh S., Lam A.K., Ho Y.H. Real-time PCR quantification of human telomerase reverse transcriptase (hTERT) in colorectal cancer. Pathology 2008, 40:25-30.
32. Scheffner M., Werness B.A., Huibregtse J.M., et al. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 1990, 63:1129-1136.
33. Schuringa J.J., Vellenga E. Role of the polycomb group gene BMI1 in normal and leukemic hematopoietic stem and progenitor cells. Current Opinion in Hematology 2010, 17:294-299.
34. Sdek P., Zhang Z.Y., Cao J., et al. Alteration of cell-cycle regulatory proteins in human oral epithelial cells immortalized by HPV16 E6 and E7. International Journal of Oral and Maxillofacial Surgery 2006, 35:653-657.
35. Shay J.W., Wright W.E. Senescence and immortalization: role of telomeres and telomerase. Carcinogenesis 2005, 26:867-874.
36. Short B., Wagey R. Isolation and culture of mesenchymal stem cells from mouse compact bone. Methods in Molecular Biology 2013, 946:335-347.
37. Skrzypczak J., Wirstlein P., Mikołajczyk M., et al. TGF superfamily and MMP2, MMP9, TIMP1 genes expression in the endometrium of women with impaired reproduction. Folia Histochemica et Cytobiologica 2007, 45:S143-S148.
38. Song L.B., Li J., Liao W.T., et al. The polycomb group protein Bmi-1 represses the tumor suppressor PTEN and induces epithelial-mesenchymal transition in human nasopharyngeal epithelial cells. The Journal of Clinical Investigation 2009, 119:3626-3636.
39. Tang W.K., Chui C.H., Fatima S., et al. Inhibitory effects of Gleditsia sinensis fruit extract on telomerase activity and oncogenic expression in human esophageal squamous cell carcinoma. International Journal of Molecular Medicine 2007, 19:953-960.
40. Tao Q., Lv B., Qiao B., et al. Immortalization of ameloblastoma cells via reactivation of telomerase function: phenotypic and molecular characteristics. Oral Oncology 2009, 45:e239-e244.
41. Yuen P.W., Man M., Lam K.Y., et al. Clinicopathological significance of p16 gene expression in the surgical treatment of head and neck squamous cell carcinomas. Journal of Clinical Pathology 2002, 55:58-60.